RNB Retail and Brands AB ("RNB" or "the Company") announces that Nasdaq Stockholm AB has today announced that the Company meets the listing requirements for Nasdaq First North Growth Market. RNB today also publishes the company description prepared in connection with the transaction that RNB published in a press release on 27 September 2021, whereby RNB intends to acquire Coala-Life AB ("Coala Life") through a non-cash issue and further carry out a change of marketplace from Nasdaq Stockholm. to Nasdaq First North Growth Market.
Provided that the Extraordinary General Meeting of RNB resolves on October 29 in accordance with the proposals in the notice convening the meeting, RNB will apply for the Company's share to be listed on the Nasdaq First North Growth Market.
The company description is available on RNB's and Coala Life's respective websites.
About Coala Life:
Coala Life is a medical device and digital health platform company active in remote and cloud-based cardiac diagnostics and remote auscultation. Coala Life has developed and launched the Coala Heart Monitor – an award-winning and FDA- and CE-approved product platform that enables long-term monitoring, analysis and algorithm-based remote diagnosis of heart and lungs. The Coala Heart Monitor and its healthcare focused Coala Care Portal are mainly marketed to caregivers who prescribe the service to patients for use in everyday life, without the need to visit any care unit. The company's solutions are based on over 10 years or R&D in Sweden and are protected by more than 30 patents. HQ’s are located in Uppsala, Sweden, and US head office is based in Irvine, CA. More than 350 healthccare providers and 1,000 physicians are connected to the Coala Care Portal. For more information see www.coalalife.com